Interim report January-June 2006

• Sales increased by 45 percent, to SEK 88.4 (60.8) million. During the second quarter sales amounted to SEK 42.5 (30.3) million, corresponding to an increase of 40 percent. The product line that was acquired during the first half of the year, fertility instruments, increased by 20 percent compared with the previous year (pro forma). • Gross income amounted to SEK 59.2 (41.8) million, an increase of 42 percent, and the gross margin to 67 percent (69). Gross income for the second quarter increased by 37 percent to SEK 29.1 (21.3) million and the gross margin was 69 (70) percent. • Operating income amounted to SEK 9.6 (6.5) million, which includes costs of a one-time nature attributable to the acquisition of Swemed of SEK 1.9 million. Last year’s operating income also included a capital gain of a one-time nature of SEK 2.4 million. Adjusted for these items operating income increased by 180 percent. For the second quarter operating income amounted to SEK 4.2 (1.1) million. • Net income for the Group was SEK 7.1 (9.0) million, of which SEK 2.8 (2.8) million was for the second quarter. This includes unrealized exchange rate effects from internal receivables of SEK -1.8 (3.1) million. • The cash flow from operating activities amounted to SEK 8.5 (1.7) million, of which SEK 8.0 (2.5) was for the second quarter. • Earnings per share amounted to SEK 0.36 (0.49). • The equity/assets ratio amounted to 78 percent (82). July 14, 2006 Kungsbacka, Sweden Magnus Nilsson CEO Queries should be addressed to: Magnus Nilsson, CEO, phone +46 31 721 80 00 or +46 708 22 80 61. Anna Ahlberg, CFO, phone +46 31 721 80 13 or +46 708 22 80 13.

---